You are at:

Cancer-Specific Killer T Cells Created from Induced Pluripotent Stem Cells (iPSC)

Researchers from the RIKEN Research Centre for Allergy and Immunology in Japan report today that they have succeeded for the first time in creating cancer-specific immune system cells called killer T lymphocytes from induced pluripotent stem cells (iPS cells). To create these killer cells, the team first had to reprogram T lymphocytes specialized in killing a certain type of cancer, into iPS cells. The iPS cells then generated fully active, cancer-specific T lymphocytes. These lymphocytes regenerated from iPS cells could potentially serve as cancer therapy in the future.
Science Daily, Dec 27, 2012
Raul Vizcardo, et al, Regeneration of Human Tumor Antigen-Specific T Cells from iPSCs Derived from Mature CD8+ T Cells.
Cell Stem Cell, 2012; 12 (1): 31-36 


Comments (2)
See Older Posts...
 You are at: